Natural killer cells in the treatment of high-risk acute leukaemia

This publication has 94 references indexed in Scilit:

• Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
  New England Journal of Medicine, 2013
• Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
  Journal of Experimental Medicine, 2012
• Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia
  Immunology & Cell Biology, 2011
• Revisiting human natural killer cell subset function revealed cytolytic CD56 ^dim CD16 ⁺ NK cells as rapid producers of abundant IFN-γ on activation
  Proceedings of the National Academy of Sciences, 2010
• Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue–inducer cell and NK cell lineages
  Nature Immunology, 2010
• Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
  Proceedings of the National Academy of Sciences, 2009
• Adaptive immune features of natural killer cells
  Nature, 2009
• Evidence for discrete stages of human natural killer cell differentiation in vivo
  Journal of Experimental Medicine, 2006
• Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus
  Nature Immunology, 2005
• MHC class I molecules and kirs in human history, health and survival
  Nature Reviews Immunology, 2005